公告称,业绩变动主要是由于以下因素所致:中国内地甜味剂产品持续供过于求,市场竞争激烈,导致市场价格持续受压。集团对甜味剂产品的产量进行了战略调整,以达致最佳生产开工率,旨在平衡集团的市场占有率与盈利能力;及本年度内并无确认以下各项: (i) 于2024年一月完成(i)中国信达资产管理股份有限公司吉林省分公司(作为债权人),(ii)锦州元成生化科技有限公司(作为债务人),及(iii)上海好成食品发展有限公司(作为担保人)(后两者均为公司的间接全资附属公司)订立的债务重组协议后取得的一次性收益约1.676亿港元;及 (ii) 就于2024年4月出售公司的前全资附属公司大成零售投资有限公司及其附属公司取得的一次性收益约4220万港元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.